Wiendah Hamidah: Inside Indonesia’s Medicine Supply Chain

A supply chain few people see

Just north of Australia, Indonesia runs one of the world’s most complex healthcare supply chains. Medicines and medical devices have to reach hospitals and community health services spread across thousands of islands, from Aceh in the far west to Papua in the east. Much of that work is done by licensed private distributors, known in Indonesia as Pedagang Besar Farmasi (PBF), or pharmaceutical wholesalers.

One of those distributors is PT Imar Karya Tama, based in Waru, Sidoarjo, on the edge of Surabaya in East Java. Its director is Wiendah Hamidah, S.Si., Apt., a pharmacist who says plainly that she is the one who runs everything at the company.

Trained at one of Indonesia’s leading universities

Wiendah Hamidah studied pharmacy at Universitas Padjadjaran in Bandung, West Java, one of Indonesia’s best-known public universities. She enrolled in 1995 and graduated with her bachelor’s degree in pharmacy (Sarjana Farmasi) in 2000. She later completed the professional pharmacist programme at the same university, qualifying as an apoteker, a licensed pharmacist, in 2021.

Those two qualifications explain her title, S.Si., Apt., and they shape how she leads. In pharmaceutical distribution, a product is only as safe as the way it has been stored, documented and delivered. A director who understands pharmacy brings that awareness to every commercial decision.

From three people to twenty-five

PT Imar Karya Tama began operating in 2016 with a team of just three. Today it employs 25 people and, in Wiendah Hamidah’s words, supplies medicines to almost every part of Indonesia.

The company distributes pharmaceutical preparations, food supplements, over-the-counter and generic medicines, single-use medical consumables, and small and large medical equipment. For a business of its size, the reach is notable. It reflects a lean organisation where the director stays close to customers, suppliers and regulators alike.

Compliance as a business model

Indonesia regulates medicine and medical device distribution closely, and distributors have to prove they meet national standards before hospitals and government buyers will work with them. PT Imar Karya Tama holds a pharmaceutical wholesaler licence, valid across Indonesia, that names Wiendah Hamidah as director.

In January 2024 the company received a Good Distribution Practice certificate for medicines, known locally as CDOB, issued on behalf of the Indonesian Food and Drug Authority (BPOM). In August 2024 it received the equivalent certificate for medical devices, known as CDAKB. That certificate covers non-radiation electromedical devices, sterile and non-sterile non-electromedical devices, and in vitro diagnostic products. Both run until 2029.

Gaining the device certificate required a quality manual, internal audits, management reviews, documented procedures and a full audit of the company’s distribution facilities. Readers familiar with GDP or ISO-style quality systems in Australia will recognise the discipline involved. For a 25-person company, it is a substantial commitment, and it creates a barrier to entry that protects the business.

Trusted by public hospitals and health offices

PT Imar Karya Tama’s customer list for 2020 to 2025 shows how far that trust extends. It includes Indonesia’s Ministry of Health, the Ministry of Marine Affairs and Fisheries and the national audit agency BPKP. It also features major public hospitals such as RSUD Dr. Soetomo in Surabaya, RSUP Dr. Sardjito in Yogyakarta and RSUP Dr. Hasan Sadikin in Bandung.

Just as important are the district and city health offices (Dinas Kesehatan) that buy from the company, from Aceh Utara and Nias in the west to Sorong, Paniai and Maluku in the east. Many of these customers return year after year. In public procurement, where every purchase must be accounted for, repeat business is a strong signal of reliability.

Values that guide the business

The company describes its vision as becoming a trusted, professional and beneficial trading and services company in the health sector. Its values are integrity, professionalism, quality, collaboration, innovation and sustainability. It also says it uses digital information systems to integrate its distribution operations and follows operating procedures based on international standards.

Why it matters

For an Australian audience, Wiendah Hamidah’s story offers a view of how Indonesia’s healthcare system actually works on the ground. Large hospitals and national programmes depend on mid-sized, well-run distributors that know the regulations and the regions. Leaders like her, who combine professional pharmacy training with hands-on management, are a big part of what keeps that system moving.

From a team of three in 2016 to a certified distributor serving customers across the archipelago, PT Imar Karya Tama shows that steady growth, proper licensing and consistent service can build lasting credibility in a demanding market.

Sources: information from Wiendah Hamidah (November 2026) and the PT Imar Karya Tama Company Profile, January 2026. Connect with Wiendah Hamidah on LinkedIn.